Quinn Wilojanapa

Associate

Pittsburgh + 1.412.394.7920

Contact

Partager

Quinn Wilojanapa advises public and private companies on mergers and acquisitions and other strategic transactions. Her experience includes domestic and cross-border matters in a range of industries, including automotive, health care, consumer products, and technology. In addition, she has experience advising companies on corporate governance matters and shareholder engagement.

Recently, Quinn assisted with Bora Pharmaceuticals' acquisition of the GMP manufacturing operations of MacroGenics (Nasdaq: MGNX) for $122.5 million cash.

Quinn also maintains an active pro bono practice and is involved with the Pittsburgh Start Anew Clinic, which brings together community partners to provide job readiness, financial literacy, and other resources for survivors of human trafficking, domestic violence, and sexual abuse.

Quinn is author of "Do You Need This Drug? Television Ads Say 'Yes,' but the FCC Should Say 'No': A Blackout on Direct-to-Consumer Prescription Drug Advertisements," 86 U. Pitt. L. Rev. 851 (2025).

Expérience

  • Bora Pharmaceuticals acquires MacroGenics, Inc.'s GMP manufacturing operationsJones Day represented Bora Pharmaceuticals Co., Ltd. in its acquisition of the GMP manufacturing operations, including the CDMO business, of MacroGenics, Inc. (Nasdaq: MGNX) for $122.5 million cash.
  • Boviet Solar Technology sells U.S. PV module manufacturing and PV cell manufacturing assets to INOX Solar Americas for approximately $750 millionJones Day advised Boviet Solar USA Ltd, a leading solar technology company specializing in manufacturing top-performing Gamma Series™ Monofacial and Vega Series™ Bifacial PV modules, in the sale of its U.S.-based subsidiaries', Boviet Solar Technology (North Carolina) LLC, and Boviet Solar Cell Technology (North Carolina) LLC, assets to INOX Solar Americas, LLC, a U.S.-based renewable energy company backed by INOX Clean Energy Limited, for approximately $750 million.
    •

    Avant d’envoyer cet e-mail, veuillez prendre note de ce qui suit :

    Les informations contenues sur le site www.jonesday.com sont destinées à un usage général et ne constituent pas des conseils juridiques. L’envoi et la réception de cet e-mail n’ont pas pour effet de créer une relation avocat-client. Aucun envoi de votre part à un membre du Cabinet ne sera traité comme confidentiel ou protégé à moins que nous n’ayons donné notre accord pour vous représenter. En envoyant cet e-mail, vous confirmez avoir lu et compris la présente notification.